cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2020-35-1-142-150cardiotomsk-925Research ArticleЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯEXPERIMENTAL STUDIESПолиморфизм генов фолатного цикла у больных подагрой в популяции русских Забайкальского краяPolymorphism in folate cycle genes in patients with gout in the Russian population of Trans-Baikal Territoryhttps://orcid.org/0000-0002-0350-0698КушнаренкоН. Н.KushnarenkoN. N.

39A, Gorky str., Chita, 672090, Russian Federation

natalia.kushnarenko1@gmail.comhttps://orcid.org/0000-0003-3243-2951МишкоМ. Ю.MishkoM. Yu.

Assistant Professor, Department of Internal Medicine, Pediatric and Dental Faculties

39A, Gorky str., Chita, 672090, Russian Federation

mm_you@mail.ruhttps://orcid.org/0000-0001-8410-5827МедведевТ. А.MedvedevaT. A.

Assistant Professor, Department of Internal Medicine, Pediatric and Dental Faculties 

39A, Gorky str., Chita, 672090, Russian Federation

saidi-tma@mail.ruЧитинская государственная медицинская академия Министерства здравоохранения Российской ФедерацииРоссияChita State Medical AcademyRussian Federation202012042020351142150Copyright © Кушнаренко Н.Н., Мишко М.Ю., Медведев Т.А., 20202020Кушнаренко Н.Н., Мишко М.Ю., Медведев Т.А.Kushnarenko N.N., Mishko M.Y., Medvedeva T.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/925подаграмочевая кислотагенетический полиморфизмфолатный циклMTHFRMTRMTRRgouturic acidgenetic polymorphismfolate cycleMTHFRMTRMTRRReferencesГринштейн Ю.И., Шабалин В.В., Руф Р.Р., Петрова М.М., Артюхов И.П., Шальнова С. А. Взаимосвязь гиперурикемии, функции почек и артериальной гипертонии у населения крупного региона Восточной Сибири. Российский кардиологический журнал. 2017;(6):86–91. DOI: 10.15829/1560-4071-2017-6-86-91.Grinshtein Y.I., Shabalin V.V., Ruf R.R., Petrova М.М., Artyukhov I.P., Shalnova S.А. Relation of hyperuricaemia, renal function and arterial hypertension in a large region of the eastern Siberia inhabitants. Russian Journal of Cardiology. 2017;(6):86–91 (In Russ.). DOI: 10.15829/1560-4071-2017-6-86-91.Елисеев М.С., Новикова А.М. Коморбидность при подагре и гиперурикемии: распространенность, причины, перспективы уратснижающей терапии. Терапевтический архив. 2019;91(5):120–128. DOI: 10.26442/00403660.2019.05.000232.Eliseev M.S., Novikova A.M. Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy. Therapeutic Archive. 2019;91(5):120–128 (In Russ.). DOI: 10.26442/00403660.2019.05.000232.Wei C.Y., Sun C.C., Wei J.C., Tai H.C., Sun C.A., Chung C.F. et al. Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan. BioMed. Research International. 2015;(7):369179. DOI: 10.1155/2015/369179.Wei C.Y., Sun C.C., Wei J.C., Tai H.C., Sun C.A., Chung C.F. et al. Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan. BioMed. Research International. 2015;(7):369179. DOI: 10.1155/2015/369179.Vedder D., Walrabenstein W., Heslinga M., de Vries R., Nurmohamed M., van Schaardenburg D. et al. Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review. Nutrients. 2019;11(12):2955. DOI: 10.3390/nu11122955.Vedder D., Walrabenstein W., Heslinga M., de Vries R., Nurmohamed M., van Schaardenburg D. et al. Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review. Nutrients. 2019;11(12):2955. DOI: 10.3390/nu11122955.Li R., Yu K., Li C. Dietary factors and risk of gout and hyperuricemia: a meta- analysis and systematic review. Asia Pac. J. Clin. Nutr. 2018;27(6):1344–1356. DOI: 10.6133/apjcn.201811_27(6).0022.Li R., Yu K., Li C. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review. Asia Pac. J. Clin. Nutr. 2018;27(6):1344–1356. DOI: 10.6133/apjcn.201811_27(6).0022.Merriman T.R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res. Ther. 2015;17:98. DOI: 10.1186/s13075-015-0609-2.Merriman T.R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res. Ther. 2015;17:98. DOI: 10.1186/s13075-015-0609-2.Dalbeth N., Stamp L.K., Merriman T.R. The genetics of gout: towards personalised medicine? BMC Medicine. 2017;15(1):108. DOI: 10.1186/s12916-017-0878-5.Dalbeth N., Stamp L.K., Merriman T.R. The genetics of gout: towards personalised medicine? BMC Medicine. 2017;15(1):108. DOI: 10.1186/s12916-017-0878-5.Кушнаренко Н.Н., Мишко М.Ю., Медведева Т.А., Витковский Ю.А. Полиморфизм гена ABCG2 у больных подагрой в Забайкальском крае. Комплексные проблемы сердечно-сосудистых заболеваний. 2019;8(2):77–86. DOI: 10.17802/2306-1278-2019-8-2-77-86.Kushnarenko N.N., Mishko M.Y., Medvedeva T.A., Vitkovsky Y.A. ABCG2 gene polymorphism in patients with gout in Zabaikalsky Krai. Complex Issues of Cardiovascular Diseases. 2019;8(2):77–86 (In Russ.). DOI: 10.17802/2306-1278-2019-8-2-77-86).Hiraoka M., Kagawa Y. Genetic polymorphisms and folate status. Congenital Anomalies. 2017;57(5):142–149. DOI: 10.1111/cga.12232.Hiraoka M., Kagawa Y. Genetic polymorphisms and folate status. Congenital Anomalies. 2017;57(5):142–149. DOI: 10.1111/cga.12232.Li W.X., Cheng F., Zhang A.J., Dai S.X., Li G.H., Lv W.W. et al. Folate deficiency and gene polymorphisms of MTHFR, MTR and MTRR elevate the hyperhomocysteinemia risk. Clin. Lab. 2017;63(3):523–533. DOI: 10.7754/Clin.Lab.2016.160917.Li W.X., Cheng F., Zhang A.J., Dai S.X., Li G.H., Lv W.W. et al. Folate deficiency and gene polymorphisms of MTHFR, MTR and MTRR elevate the hyperhomocysteinemia risk. Clin. Lab. 2017;63(3):523–533. DOI: 10.7754/Clin.Lab.2016.160917.Liew S.C., Gupta E.D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur. J. Med. Genet. 2015;58(1):1–10. DOI: 10.1016/j.ejmg.2014.10.004.Liew S.C., Gupta E.D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur. J. Med. Genet. 2015;58(1):1–10. DOI: 10.1016/j.ejmg.2014.10.004.Nazki F.H., Sameer A.S., Ganaie B.A. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533(1):11–20. DOI: 10.1016/j.gene.2013.09.063.Nazki F.H., Sameer A.S., Ganaie B.A. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533(1):11–20. DOI: 10.1016/j.gene.2013.09.063.Yuan Y., Shao W., Li Y. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol. Int. 2017;37(4):557–569. DOI: 10.1007/s00296-017-3650-4.Yuan Y., Shao W., Li Y. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol. Int. 2017;37(4):557–569. DOI: 10.1007/s00296-017-3650-4.Zhao M., Wang X., He M., Qin X., Tang G., Huo Y. et al. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48(5):1183–1190. DOI: 10.1161/STROKEAHA.116.015324.Zhao M., Wang X., He M., Qin X., Tang G., Huo Y. et al. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48(5):1183–1190. DOI 10.1161/STROKEAHA.116.015324.Levin B.L., Varga E. MTHFR: Addressing genetic counseling dilemmas using evidence-based literature. J. Genet. Couns. 2016;25(5):901–911. DOI: 10.1007/s10897-016-9956-7.Levin B.L., Varga E. MTHFR: Addressing genetic counseling dilemmas using evidence-based literature. J. Genet. Couns. 2016;25(5):901–911. DOI: 10.1007/s10897-016-9956-7.Hong Y.S., Lee M.J, Kim K.H., Lee S.H., Lee Y.H., Kim B.G. et al. The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J. Korean. Med. Sci. 2004;19(2):209–213. DOI: 10.3346/jkms.2004.19.2.209.Hong Y.S., Lee M.J, Kim K.H., Lee S.H., Lee Y.H., Kim B.G. et al. The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J. Korean. Med. Sci. 2004;19(2):209–213. DOI: 10.3346/jkms.2004.19.2.209.Zuo M., Nishio H., Lee M.J., Maejima K., Mimura S., Sumino K. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J. Hum. Genet. 2000;45:257–262. DOI: 10.1007/s100380070037.Zuo M., Nishio H., Lee M.J., Maejima K., Mimura S., Sumino K. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J. Hum. Genet. 2000;45:257–262. DOI: 10.1007/s100380070037.Van der Heijde D., Aletaha D., Carmona L., Edwards C.J., Kvien T.K., Kouloumas M. et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann. Rheum. Dis. 2015;74(1):8–13. DOI: 10.1136/annrheumdis-2014-206350.Van der Heijde D., Aletaha D., Carmona L., Edwards C.J., Kvien T.K., Kouloumas M. et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann. Rheum. Dis. 2015;74(1):8–13. DOI: 10.1136/annrheumdis-2014-206350.Itou S., Goto Y., Suzuki K., Kawai S., Naito M., Ito Y. et al. Significant association between methylenetetrahydrofolate reductase 677T allele and hyperuricemia among adult Japanese subjects. Nutr. Res. 2009;29(10):710–715. DOI: 10.1016/j.nutres.2009.10.006.Itou S., Goto Y., Suzuki K., Kawai S., Naito M., Ito Y. et al. Significant association between methylenetetrahydrofolate reductase 677T allele and hyperuricemia among adult Japanese subjects. Nutr. Res. 2009;29(10):710–715. DOI: 10.1016/j.nutres.2009.10.006.

The authors declare that there are no conflicts of interest present.